Rafael Holdings, Inc. has entered into a merger agreement with Cyclo Therapeutics, Inc., which involves Rafael acquiring Cyclo, pending stockholder approvals and other conditions, with Cyclo's shares valued at $0.95 each.
AI Assistant
RAFAEL HOLDINGS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.